Page last updated: 2024-08-23

vx and lumacaftor

vx has been researched along with lumacaftor in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Heneghan, M; Murphy, J; Nevitt, SJ; Sinha, IP; Southern, KW1

Reviews

1 review(s) available for vx and lumacaftor

ArticleYear
Corrector therapies (with or without potentiators) for people with cystic fibrosis with class II CFTR gene variants (most commonly F508del).
    The Cochrane database of systematic reviews, 2023, 11-20, Volume: 11

    Topics: Adult; Aminophenols; Child; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Dyspnea; Humans; Mutation

2023